www.cnbc.com
The continent’s pharmaceutical industry faces significant impact due to President Trump’s latest tariffs on specific European nations. This new protectionist measure threatens to disrupt long-standing transatlantic supply chains and potentially increase costs for both European manufacturers and American patients relying on European-sourced medicines. The sector is bracing for potential economic strain as trade tensions escalate.
Read More
